[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Evidence-Based Dermatology: Research Commentary
September 2001

Sentinel Node Biopsy for Melanoma: What Is the Evidence?

Arch Dermatol. 2001;137(9):1228-1231. doi:10.1001/archderm.137.9.1228

Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous Melanoma

Blaheta H-J, Ellwanger U, Schittek B, Sotlar K, Maczey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G, Garbe C

J Invest Dermatol. 2000;114:637-642

Blaheta et al conducted a prospective cohort study on 116 patients with newly diagnosed primary cutaneous melanoma greater than or equal to 0.9 mm in Breslow depth. No patients showed evidence of metastatic disease and all underwent sentinel lymph node (SLN) biopsy.

First Page Preview View Large
First page PDF preview
First page PDF preview